Published On : December 2017 Pages : 127 Category: Biotechnology Report Code : HC12396
Industry Outlook and Trend Analysis
The Infertility Treatment Market was worth USD 0.78 billion in the year of 2017 and is expected to reach approximately USD 1.93 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 10.63% during the forecast period. Factors, for example, funds ad grants; continuous decline in fertility rates, developing awareness of the public about infertility and the accessible treatment alternatives; the rising number of fertility clinics around the world; and mechanical progressions in infertility treatment are the significant drivers for the development of the market of infertility treatment. However, the high procedural cost of helped conceptive systems in developed markets and unsupportive government controls for certain infertility treatment alternatives are relied upon to constrain market development to a specific degree.
Procedure Outlook and Trend Analysis
On the basis of procedure, the infertility treatment market is sectioned into artificial insemination (AI), fertility surgeries, assisted reproductive technology (ART), and different procedures (embryo freezing, egg freezing, and sperm freezing). The ART portion represented the biggest offer of the infertility treatment market in 2017 on the basis of procedure attributable to growing adoption of procedures like surrogacy by same-sex couples, increasing infertility and rising prevalence of lifestyle issues, the high success rate of ART procedures, and technological innovations in the field of IVF. The ART market is further sub segmented into surrogacy, and in vitro fertilization (IVF). The IVF fragment holds the biggest share in the ART market. The vast offer of the IVF portion can be credited to the high achievement rate related with the methodology and developing awareness and social acknowledgment of this strategy.
Product Outlook and Trend Analysis
In terms of product, the infertility treatment market is divided into media & consumables, accessories, and instruments. In 2017 the instruments fragment represented the biggest share of the market. The instruments fragment is further sub sectioned into eight products, incubators, imaging & laser systems, workstations, ovum aspiration pumps, sperm analyzers, gas analyzers and micromanipulator systems. The imaging systems product section held the biggest share of the instruments market in 2017, attributable to components, for example, expanding usage of imaging systems in infertility treatment procedures and mechanical progressions by enter players in imaging modalities.
Patient Type Outlook and Trend Analysis
On the basis of patient type, the infertility treatment market is portioned into female patients and male patients. In 2017, the female patients fragment represented the biggest share of the market, principally because of the diminishing female fertility rates and the accessibility of an extensive variety of treatment alternatives.
End User Outlook and Trend Analysis
On the basis of end user, the infertility treatment market is segmented into fertility centers, research institutes, hospitals & clinics, and cryobanks. Rising rate of infertility and other lifestyle disorders has prompted increased adoption of infertility treatment in various end user sectors thereby boosting the development of the market.
Regional Outlook and Trend Analysis
Geographically, the market is segmented into Asia Pacific, North America, Europe and Rest of the world. In 2017 North America held the biggest offer of the market, trailed by Asia-Pacific and Europe. The Asia-Pacific district is foreseen to develop at a significant CAGR amid the figure time frame. This development can be credited to elements, for example, reductions in treatment prices, increasing medical tourism, increasing population, growing healthcare expenditure.
Competitive Insights
The leading players in the market are Irvine Scientific, Esco Micro Pte. Ltd, IVFtech ApS, The Baker Company Inc, Thermo Fisher Scientific Inc, Vitrolife AB, Cook Group Incorporated and Genea Limited. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Infertility Treatment Market is segmented as follows-
By Procedure
By Product
By Patient Type
By End User
By Region
Some of the key questions answered by the report are:
Market Classification
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Growing Number of Fertility Clinics Worldwide
3.2.1.2. Technical Advancements in Infertility Treatment Devices
3.2.2. Restraints
3.2.2.1. High Procedural Cost of Assisted Reproductive Techniques
3.2.3. Opportunities
4. Infertility Treatment Market, By Procedure
4.1. Introduction
4.2. Infertility Treatment Market Assessment and Forecast, By Procedure, 2017-2023
4.3. Artificial Insemination
4.3.1. Market Assessment and Forecast, By Type, 2017-2023 ($Million)
4.3.2. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
4.3.3. Intrauterine Insemination
4.3.3.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
4.3.4. Intracervical Insemination
4.3.4.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
4.3.5. Intratubal Insemination
4.3.5.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
4.4. Assisted Reproductive Technology (ART)
4.4.1. Market Assessment and Forecast, By Type, 2017-2023 ($Million)
4.4.2. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
4.4.3. In-vitro Fertilization (IVF)
4.4.3.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
4.4.4. Surrogacy
4.4.4.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
4.5. Fertility Surgeries
4.5.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
4.6. Other Procedures (Sperm Freezing, Egg Freezing, and Embryo Freezing)
4.6.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
5. Infertility Treatment Market, By Product
5.1. Introduction
5.2. Infertility Treatment Market Assessment and Forecast, By Product, 2017-2023
5.3. Media & Consumables
5.3.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
5.4. Instruments
5.4.1. Market Assessment and Forecast, By Type, 2017-2023 ($Million)
5.4.2. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
5.4.3. Micromanipulator Systems
5.4.3.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
5.4.4. Laser Systems
5.4.4.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
5.4.5. Imaging Systems
5.4.5.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
5.5. Accessories
5.5.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
6. Infertility Treatment Market, By Patient Type
6.1. Introduction
6.2. Infertility Treatment Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
6.3. Female Treatment
6.3.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
6.4. Male Treatment
6.4.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
7. Infertility Treatment Market, By End User
7.1. Introduction
7.2. Infertility Treatment Market Assessment and Forecast, By Product, 2017-2023
7.3. Research Institutes
7.3.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
7.4. Fertility Centers
7.4.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
7.5. Hospitals and Clinics
7.5.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
7.6. Cryobanks
7.6.1. Market Assessment and Forecast, By Region, 2017-2023 ($Million)
8. Infertility Treatment Market, By Region
8.1. Introduction
8.2. Infertility Treatment Market Assessment and Forecast, By Region, 2017-2023 ($Million)
8.3. North America
8.3.1. Market Assessment and Forecast, By Country, 2017-2023 ($Million)
8.3.2. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.3.3. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.3.4. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.3.5. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.3.5.1. U.S.
8.3.5.1.1. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.3.5.1.2. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.3.5.1.3. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.3.5.1.4. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.3.5.2. Canada
8.3.5.2.1. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.3.5.2.2. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.3.5.2.3. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.3.5.2.4. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.3.5.3. Mexico
8.3.5.3.1. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.3.5.3.2. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.3.5.3.3. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.3.5.3.4. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.4. Europe
8.4.1. Market Assessment and Forecast, By Country, 2017-2023 ($Million)
8.4.2. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.4.3. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.4.4. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.4.5. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.4.5.1. Germany
8.4.5.1.1. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.4.5.1.2. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.4.5.1.3. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.4.5.1.4. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.4.5.2. France
8.4.5.2.1. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.4.5.2.2. Market Assessment and Forecast, By Products, 2017-2023 ($Million)
8.4.5.2.3. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.4.5.2.4. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.4.5.3. UK
8.4.5.3.1. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.4.5.3.2. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.4.5.3.3. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.4.5.3.4. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.4.5.4. Italy
8.4.5.4.1. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.4.5.4.2. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.4.5.4.3. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.4.5.4.4. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.4.5.5. Spain
8.4.5.5.1. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.4.5.5.2. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.4.5.5.3. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.4.5.5.4. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.4.5.6. Rest of Europe
8.4.5.6.1. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.4.5.6.2. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.4.5.6.3. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.4.5.6.4. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.5. Asia-Pacific
8.5.1. Market Assessment and Forecast, By Country, 2017-2023 ($Million)
8.5.2. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.5.3. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.5.4. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.5.5. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.5.5.1. Japan
8.5.5.1.1. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.5.5.1.2. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.5.5.1.3. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.5.5.1.4. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.5.5.2. China
8.5.5.2.1. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.5.5.2.2. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.5.5.2.3. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.5.5.2.4. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.5.5.3. Australia
8.5.5.3.1. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.5.5.3.2. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.5.5.3.3. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.5.5.3.4. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.5.5.4. India
8.5.5.4.1. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.5.5.4.2. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.5.5.4.3. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.5.5.4.4. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.5.5.5. South Korea
8.5.5.5.1. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.5.5.5.2. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.5.5.5.3. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.5.5.5.4. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.5.5.6. Rest of Asia-Pacific
8.5.5.6.1. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.5.5.6.2. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.5.5.6.3. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.5.5.6.4. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.6. Rest of the World
8.6.1. Market Assessment and Forecast, By Country, 2017-2023 ($Million)
8.6.2. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.6.3. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.6.4. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.6.5. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.6.5.1. Brazil
8.6.5.1.1. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.6.5.1.2. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.6.5.1.3. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.6.5.1.4. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.6.5.2. Turkey
8.6.5.2.1. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.6.5.2.2. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.6.5.2.3. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.6.5.2.4. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.6.5.3. Saudi Arabia
8.6.5.3.1. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.6.5.3.2. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.6.5.3.3. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.6.5.3.4. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.6.5.4. South Africa
8.6.5.4.1. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.6.5.4.2. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.6.5.4.3. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.6.5.4.4. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.6.5.5. United Arab Emirates
8.6.5.5.1. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.6.5.5.2. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.6.5.5.3. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.6.5.5.4. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
8.6.5.6. Others
8.6.5.6.1. Market Assessment and Forecast, By Procedure, 2017-2023 ($Million)
8.6.5.6.2. Market Assessment and Forecast, By Product, 2017-2023 ($Million)
8.6.5.6.3. Market Assessment and Forecast, By Patient Type, 2017-2023 ($Million)
8.6.5.6.4. Market Assessment and Forecast, By End User, 2017-2023 ($Million)
9. Company Profiles
9.1. Cook Group Incorporated
9.1.1. Business Overview
9.1.2. Product Portfolio
9.1.3. Strategic Developments
9.2. Thermo Fisher Scientific, Inc.
9.2.1. Business Overview
9.2.2. Product Portfolio
9.2.3. Strategic Developments
9.3. Vitrolife AB
9.3.1. Business Overview
9.3.2. Product Portfolio
9.3.3. Strategic Developments
9.4. Esco Micro Pte. Ltd.
9.4.1. Business Overview
9.4.2. Product Portfolio
9.4.3. Strategic Developments
9.5. Genea Limited
9.5.1. Business Overview
9.5.2. Product Portfolio
9.5.3. Strategic Developments
9.6. IVFtech ApS
9.6.1. Business Overview
9.6.2. Product Portfolio
9.6.3. Strategic Developments
9.7. Irvine Scientific
9.7.1. Business Overview
9.7.2. Product Portfolio
9.7.3. Strategic Developments
9.8. The Baker Company, Inc.
9.8.1. Business Overview
9.8.2. Product Portfolio
Strategic Developments
List of Tables
Table 1.Infertility Treatment Market, By Procedure ($Million), 2017-2023
Table 2.Artificial Insemination Market, By Region ($Million), 2017-2023
Table 3.Intrauterine Insemination Market, By Region ($Million), 2017-2023
Table 4.Intracervical Insemination Market, By Region ($Million), 2017-2023
Table 5.Intratubal Insemination Market, By Region ($Million), 2017-2023
Table 6.Assisted Reproductive Technology (ART) Market, By Region ($Million), 2017-2023
Table 7.In-vitro Fertilization (IVF) Market, By Region ($Million), 2017-2023
Table 8.Surrogacy Market, By Region ($Million), 2017-2023
Table 9.Fertility Surgeries Market, By Region ($Million), 2017-2023
Table 10.Other Procedures (Sperm Freezing, Egg Freezing, and Embryo Freezing) Market, By Region ($Million), 2017-2023
Table 11.Infertility Treatment Market, By Product ($Million), 2017-2023
Table 12.Media & Consumables Market, By Region ($Million), 2017-2023
Table 13.Instruments Market, By Region ($Million), 2017-2023
Table 14.Micromanipulator Systems Market, By Region ($Million), 2017-2023
Table 15.Laser Systems Market, By Region ($Million), 2017-2023
Table 16.Imaging Systems Market, By Region ($Million), 2017-2023
Table 17.Accessories Market, By Region ($Million), 2017-2023
Table 18.Infertility Treatment Market, By Patient Type ($Million), 2017-2023
Table 19.Female Treatment Market, By Region ($Million), 2017-2023
Table 20.Male Treatment Market, By Region ($Million), 2017-2023
Table 21.Infertility Treatment Market, By End User ($Million), 2017-2023
Table 22.Research Institutes Market, By Region ($Million), 2017-2023
Table 23.Fertility Centers Market, By Region ($Million), 2017-2023
Table 24.Hospitals and Clinics Market, By Region ($Million), 2017-2023
Table 25.Cryobanks, By Region ($Million), 2017-2023
Table 26.Infertility Treatment Market, By Region ($Million), 2017-2023
Table 27.North America Infertility Treatment Market, By Country, 2017-2023 ($Million)
Table 28.North America Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 29.North America Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 30.North America Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 31.North America Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 32.U.S. Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 33.U.S. Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 34.U.S. Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 35.U.S. Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 36.Canada Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 37.Canada Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 38.Canada Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 39.Canada Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 40.Mexico Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 41.Mexico Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 42.Mexico Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 43.Mecixo Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 44.Europe Infertility Treatment Market, By Country, 2017-2023 ($Million)
Table 45.Europe Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 46.Europe Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 47.Europe Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 48.Europe Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 49.Germany Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 50.Germany Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 51.Germany Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 52.Germany Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 53.France Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 54.France Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 55.France Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 56.France Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 57.UK Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 58.UK Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 59.UK Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 60.UK Market, By End User, 2017-2023 ($Million)
Table 61.Italy Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 62.Italy Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 63.Italy Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 64.Italy Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 65.Spain Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 66.Spain Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 67.Spain Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 68.Spain Market, By End User, 2017-2023 ($Million)
Table 69.Rest of Europe Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 70.Rest of Europe Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 71.Rest of Europe Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 72.Rest of Europe Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 73.Asia-Pacific Infertility Treatment Market, By Country, 2017-2023 ($Million)
Table 74.Asia-Pacific Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 75.Asia-Pacific Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 76.Asia-Pacific Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 77.Asia-Pacific Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 78.Japan Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 79.Japan Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 80.Japan Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 81.Japan Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 82.China Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 83.China Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 84.China Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 85.China Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 86.Australia Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 87.Australia Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 88.Australia Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 89.Australia Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 90.India Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 91.India Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 92.India Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 93.India Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 94.South Korea Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 95.South Korea Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 96.South Korea Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 97.South Korea Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 98.Rest of Asia-Pacific Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 99.Rest of Asia-Pacific Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 100.Rest of Asia-Pacific Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 101.Rest of Asia-Pacific Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 102.Rest of the World Infertility Treatment Market, By Country, 2017-2023 ($Million)
Table 103.Rest of the World Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 104.Rest of the World Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 105.Rest of the World Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 106.Rest of the World Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 107.Brazil Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 108.Brazil Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 109.Brazil Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 110.Brazil Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 111.Turkey Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 112.Turkey Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 113.Turkey Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 114.Turkey Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 115.Saudi Arabia Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 116.Saudi Arabia Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 117.Saudi Arabia Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 118.Saudi Arabia Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 119.South Africa Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 120.South Africa Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 121.South Africa Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 122.South Africa Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 123.United Arab Emirates Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 124.United Arab Emirates Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 125.United Arab Emirates Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 126.United Arab Emirates Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 127.Others Infertility Treatment Market, By Procedure, 2017-2023 ($Million)
Table 128.Others Infertility Treatment Market, By Product, 2017-2023 ($Million)
Table 129.Others Infertility Treatment Market, By Patient Type, 2017-2023 ($Million)
Table 130.Others Infertility Treatment Market, By End User, 2017-2023 ($Million)
Table 131.Cook Group Incorporated: Key Strategic Developments, 2017-2017
Table 132.Thermo Fisher Scientific, Inc.: Key Strategic Developments, 2017-2017
Table 133.Vitrolife AB: Key Strategic Developments, 2017-2017
Table 134.Esco Micro Pte. Ltd.: Key Strategic Developments, 2017-2017
Table 135.Genea Limited: Key Strategic Developments, 2017-2017
Table 136.IVFtech ApS: Key Strategic Developments, 2017-2017
Table 137.Irvine Scientific: Key Strategic Developments, 2017-2017
Table 138.The Baker Company, Inc.: Key Strategic Developments, 2017-2017
List of Figures
Figure 1.Infertility Treatment Market Share, By Procedure, 2017 & 2023 ($Million)
Figure 2.Infertility Treatment Market, By Product, 2017 & 2023 ($Million)
Figure 3.Infertility Treatment Market, By Patient Type, 2017 & 2023 ($Million)
Figure 4.Infertility Treatment Market, By Patient Type, 2017 & 2023 ($Million)
Figure 5.Infertility Treatment Market, By Region, 2017, ($Million)
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
Data Collection Matrix |
Supply Side |
Demand Side |
Primary Data Sources |
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
Qualitative Data |
Quantitative Data (2017-2025) |
|
|